---
title: 'Vice President, Program Leadership (Launch Products) at Mirum Pharmaceuticals'
canonical: 'https://feeny.ai/job/vice-president-program-leadership-launch-products-mirum-pharmaceuticals-foster-ah28g7q6rnzr'
type: 'job'
last_seen: '2026-10-21'
---

# Vice President, Program Leadership (Launch Products) at Mirum Pharmaceuticals

- **Company:** Mirum Pharmaceuticals
- **Location:** Foster City, CA
- **Posted:** 2026-10-20
- **Last confirmed live:** 2026-10-21
- **Apply:** https://job-boards.greenhouse.io/mirumpharmaceuticals/jobs/5270615007

## Job description

## MISSION

Mirum Pharmaceuticals is a biopharmaceutical company dedicated to transforming the treatment of rare diseases. We are passionate about advancing scientific discoveries to become important medicines for rare disease patients. We are collaborative, creative, and experienced professionals and we’re looking to augment our team with other individuals who embody our values: care, be real, get it done, and have fun, seriously.

## POSITION SUMMARY

The VP, Program Leadership (Launch Products) is accountable for defining and driving the global strategy to maximize the long-term value of Mirum’s late-stage products. The Program Leader leads a cross-functional team spanning U.S. and International Commercial, Development, Regulatory, Medical Affairs, CMC/Technical Operations, Market Access, Finance, and other functions, ensuring alignment around a single integrated product vision and strategy.

The VP, Program Leadership (Launch Products) will initially provide leadership across Mirum’s commercial-stage portfolio, including LIVMARLI, ATEBRIOZ, CHOLBAM, and CTEXLI, identifying and prioritizing opportunities to maximize patient impact and product value globally.

The Program Leader operates as “Program CEO,” leading product strategy and execution, influencing executive leadership, and bringing together cross-functional leaders around a shared vision

## JOB FUNCTIONS/RESPONSIBILITIES

Global Product Strategy and Value Maximization for Commercial Portfolio

- Define and execute the integrated global lifecycle strategy for assigned products, establishing the long-term vision and value-maximization plan, taking into account risks, tradeoffs, and value
- Identify and prioritize opportunities across geographies, indications, patient segments, formulations, evidence generation, regulatory pathways, and other lifecycle initiatives.
- Continuously reassess product strategy based on emerging clinical data, competitive developments, market dynamics, regulatory changes, product performance, and IP considerations.
- Lead the cross-functional Program Team, including representatives from U.S. and International Commercial, Development, Regulatory, Medical Affairs, CMC/Technical Operations, Market Access, Finance, Legal, and other relevant functions.
- Working closely with regional commercial leaders, evaluate geographic expansion opportunities and commercialization models, including direct entry, distributors, partnerships, and licensing.
- Lead the evaluation of new indications, expanded patient populations, label enhancements, combination strategies, and other development opportunities
- Drive cross-functional decision-making, ensuring key trade-offs and internal resource constraints are identified, evaluated, and resolved.
- Working closely with Finance and other cross-functional leaders, rationalize, get endorsement, and manage the Program Team budget, as part of the annual long-range planning exercise

Success Criteria

The successful Program Leader will:

- Lead through influence across senior cross-functional stakeholders and create accountability across organizational boundaries.
- Balance commercial opportunity with scientific, regulatory, operational, and financial considerations, making explicit strategic choices and trade-offs.
- Prioritize lifecycle opportunities and investments based on patient impact, strategic fit, value creation, probability of success, investment requirements, and organizational capacity.
- Develop and communicate business cases, investment recommendations, and strategic scenarios to executive leadership and governance committees to drive timely decisions and resource allocation.
- Translate complex information into clear recommendations and decisions.
- Maintain a global, long-term perspective while driving near-term execution
- Represent the program and Mirum externally, with thought leaders, prospective partners, and other stakeholders

## QUALIFICATIONS

Education /Experience:

- 15+ years of experience in the biopharmaceutical industry, with significant experience in commercial strategy, marketing, new product planning, global commercialization, or related leadership roles; prior experience in rare disease and/or specialty pharmaceuticals preferred.
- Demonstrated success leading global product or lifecycle strategy for marketed and/or late-stage products, including responsibility for maximizing product value across indications, geographies, patient populations, and stages of the product lifecycle.
- Strong commercial foundation, with experience developing product strategy, positioning, forecasting, market development, launch planning, competitive strategy, and long-range commercial plans.
- Global mindset and demonstrated ability to incorporate the needs and perspectives of U.S. and international markets into product strategy and investment decisions.
- Significant experience leading senior cross-functional teams spanning Commercial, Development, Medical Affairs, Regulatory, Market Access, CMC/Technical Operations, Finance, and other functions, including leadership through influence without direct authority.
- Ability to operate as an enterprise product leader, integrating commercial, clinical, regulatory, medical, technical, and financial perspectives into a cohesive product strategy.
- Strong strategic and financial acumen, including experience developing business cases, evaluating investment alternatives, understanding product P&Ls and forecasts, and making resource-allocation recommendations.
- Track record of making effective decisions in situations involving complexity, uncertainty, competing priorities, and cross-functional trade-offs.
- Strong understanding of the global biopharmaceutical commercialization environment, including the interplay among clinical evidence, regulatory strategy, market access, pricing/reimbursement, competitive dynamics, and commercial execution
- Demonstrated ability to influence and align senior executives and functional leaders, constructively challenge assumptions, resolve differences, and drive teams toward clear decisions and execution.
- Excellent executive communication skills, with the ability to synthesize complex information into clear strategic choices and recommendations for executive leadership and governance bodies.
- Strong orientation toward patient impact and value creation, with the ability to balance near-term business performance with investments that maximize the long-term potential of a product.
- Bachelor’s degree required; MBA or other advanced degree preferred.

## #LI-HYBRID

Mirum Pharmaceuticals is committed to Equal Employment Opportunity (EEO) and to compliance with all Federal, State and Local laws that prohibit employment discrimination on the basis of race, age, national origin, ethnicity, religion, gender, gender identity, pregnancy, marital status, sexual orientation, citizenship, genetic disposition or characteristics, disability, veteran’s status or any other classification protected by applicable State/Federal/Local laws.

Mirum Pharmaceuticals provides reasonable accommodation for qualified individuals with disabilities and disabled veterans in job application procedures.

## About Mirum Pharmaceuticals

## Company Overview
- **One-liner**: Mirum Pharmaceuticals is a global biopharmaceutical company focused on developing and delivering treatments for rare liver diseases affecting children and adults with significant unmet medical needs.
- **Entity Type**: Public (NASDAQ: MIRM)
- **Headquarters**: Foster City, California, USA
- **Founded**: 2018
- **Founders**: Not publicly listed as individual founders; the company was established by a leadership team with deep rare disease and biotech experience who identified a deprioritized therapy for Alagille syndrome and moved decisively to advance it.

## Core Business
- **Primary industry/industries**: Biotechnology / Rare Disease Pharmaceuticals
- **Target customers**: Healthcare providers, patients, and families affected by rare liver diseases (Alagille syndrome, Progressive Familial Intrahepatic Cholestasis, and other cholestatic conditions); B2B relationships with payers, distributors, and healthcare systems globally.
- **Mission or purpose statement**: "Relentlessly Rare" — focused on conditions where the burden is profound and the need is greatest, combining deep expertise with disciplined execution to advance meaningful medicines for people around the world.

## Products & Services
- **LIVMARLI® (maralixibat)**: An oral, once-daily ileal bile acid transporter (IBAT) inhibitor approved for the treatment of cholestatic pruritus in Alagille syndrome (ALGS) and Progressive Familial Intrahepatic Cholestasis (PFIC). Approved in multiple regions including the US and Europe. Additional development programs are underway.
- **Pipeline Programs**: A broad pipeline of investigational medicines targeting significant unmet needs in rare liver diseases, including additional indications for LIVMARLI and other early-stage programs.

## Market Standing
- **Valuation/Market Cap**: As of mid-2025, Mirum’s market capitalization is approximately $1.5–$2.0 billion (fluctuating with stock price; check current data on [ir.mirumpharma.com](https://ir.mirumpharma.com/overview/default.aspx)).
- **Key Metric**: Annual Revenue — Mirum generates revenue from commercial sales of LIVMARLI. In 2024, the company reported total revenue of approximately $290 million (preliminary figure; verify in latest 10-K). The company has transitioned from a development-stage to a commercial-stage biotech.
- **Notable Investors/Partners**: Public institutional investors; key partners include clinical sites, patient advocacy groups (e.g., Alagille Syndrome Alliance, PFIC Network), and global distribution partners for international markets.
- **Growth Signals**: Three approved medicines in its portfolio; global footprint with offices in North America and Europe; expanding pipeline with additional clinical programs; consistent revenue growth from LIVMARLI; growing commercial presence in Europe and other regions.

## Competitive Advantages
- **First-in-class / Best-in-class therapy**: LIVMARLI is the first and only approved treatment for cholestatic pruritus in Alagille syndrome, addressing a critical unmet need with no prior approved therapies.
- **Deep rare disease expertise**: The leadership team has extensive experience in rare disease drug development, regulatory strategy, and commercialization, allowing the company to navigate complex pathways efficiently.
- **Patient-centric culture**: Mirum embeds patient and family voices directly into development and commercial strategy, ensuring therapies meet real-world needs.
- **Disciplined execution**: The company was founded with a single deprioritized asset and rapidly advanced it to approval, demonstrating agility and focus.

## Strategic Focus
- **Expand global access**: Continuing to secure regulatory approvals and market access for LIVMARLI and other pipeline assets across North America, Europe, and other regions.
- **Advance pipeline**: Pursuing additional indications for LIVMARLI and developing new therapies for other rare liver diseases with high unmet need.
- **Deepen patient engagement**: Strengthening relationships with patient communities and advocacy groups to inform research, development, and commercialization.
- **Build commercial infrastructure**: Expanding commercial, medical affairs, and patient services teams globally to support growing product portfolio.

## Why Work Here
- **Mission-driven culture**: Mirum’s core values — "Care, Be Real, Get It Done, and Have Fun, Seriously" — foster a collaborative, high-performance environment where employees are empowered to bring their authentic selves to work.
- **Flexible work environment**: The company supports flexible ways of working, with offices in Foster City (global HQ), Basel (Switzerland), and Zug (Switzerland), plus US Remote roles available for certain positions. Arrangements vary by role.
- **Comprehensive benefits**: 100% employee medical premium coverage (with 100% dependent medical contributions), 4% 401(k) match with immediate vesting, 15% Employee Stock Purchase Plan, four weeks of PTO starting day one, company holidays including a winter shutdown, paid parental leave, up to $5,000 annual tuition reimbursement, and an Employee Assistance Program.
- **Collaborative community**: Regular "Coffee and Chats" and bi-weekly "Lunch Connections" foster cross-functional dialogue. Office environments are designed for connection with stocked snacks, beverages, and (in some locations) catered lunches and on-site baristas.
- **Growth opportunity**: As a high-growth public company with approved products and an expanding pipeline, employees have significant opportunities to contribute to meaningful milestones and career development.

## Sources
1. [mirumpharma.com](https://mirumpharma.com/)
2. [mirumpharma.com/about-us/our-story/](https://mirumpharma.com/about-us/our-story/)
3. [mirumpharma.com/jobs/](https://mirumpharma.com/jobs/)
4. [ir.mirumpharma.com](https://ir.mirumpharma.com/overview/default.aspx)
5. [job-boards.greenhouse.io/mirumpharmaceuticals](https://job-boards.greenhouse.io/mirumpharmaceuticals)

## Other roles at Mirum Pharmaceuticals

- [Executive Vice President, Head of International](https://feeny.ai/job/executive-vice-president-head-of-international-mirum-pharmaceuticals-foster-city-zks32xmse1bf) — Foster City, CA
- [Senior Manager, Program Management](https://feeny.ai/job/senior-manager-program-management-mirum-pharmaceuticals-foster-city-ca5ct930ztn6) — Foster City, CA
- [Senior Director, HR Business Partner](https://feeny.ai/job/senior-director-hr-business-partner-mirum-pharmaceuticals-foster-city-4hhwex05d1hc) — Foster City, CA
- [Director, Regulatory Project Management](https://feeny.ai/job/director-regulatory-project-management-mirum-pharmaceuticals-foster-city-4jg70n1k4q9c) — Foster City, CA
- [Director, Clinical Pharmacology](https://feeny.ai/job/director-clinical-pharmacology-mirum-pharmaceuticals-foster-city-hgkvgcbm9zz4) — Foster City, CA
- [Associate Director, Commercial Operations](https://feeny.ai/job/associate-director-commercial-operations-mirum-pharmaceuticals-zug-8badj97bpf21) — Zug, Switzerland
- [Therapeutic Account Manager, Liver - Baltimore](https://feeny.ai/job/therapeutic-account-manager-liver-baltimore-mirum-pharmaceuticals-baltimore-wsmckesc300t) — Baltimore, MD
- [Senior Director, Regulatory Affairs](https://feeny.ai/job/senior-director-regulatory-affairs-mirum-pharmaceuticals-foster-city-c00xsafh10k8) — Foster City, CA
- [Senior Director, Shared Services](https://feeny.ai/job/senior-director-shared-services-mirum-pharmaceuticals-foster-city-aedy0jj99pbz) — Foster City, CA
- [Therapeutic Account Manager, Liver - Houston](https://feeny.ai/job/therapeutic-account-manager-liver-houston-mirum-pharmaceuticals-houston-5vf1svcn56sh) — Houston, TX